Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

A companion magnetic sensor for in operando detection of magnetic biosynthesis in cancer and neurodegenerative models

BioMag

Iron is essential for all life forms as it is a core component of many vital metabolic processes. In humans, iron homeostasis is controlled by sophisticated processes regulating its storage, transport, and export. More recently, the role of iron in diseases also emerged with ferroptosis being a form of cell death that is implicated for instance in...

Funding Programme
Start Date
End Date
Total Funding
€ 150 000
European Countries Involved

A Foundation Model for Next-Generation Generalizable AI in Neuro-Radiology

AI-Next

Medical artificial intelligence (AI) holds immense promise for transforming radiology by introducing advanced diagnostic capabilities. Yet, traditional AI models face challenges like extensive data annotation needs and are task-specific with limited generalizability to different scenarios. This problem of robust and label-efficient generalization...

Funding Programme
Start Date
End Date
Total Funding
€ 2 533 448
European Countries Involved

A function for sleep-dependent tau dynamics

sleepyTau

Dysfunction of protein Tau is the main cause of dementia. Dementia associates with synaptic failure and sleep disturbances, but their connection remains elusive. In dementia, Tau becomes hyperphosphorylated (p-Tau) causing synaptic loss. Temperature fluctuations also associate with Tau phosphorylation, for example in hibernating animals...

Funding Programme
Start Date
End Date
Total Funding
€ 175 920
European Countries Involved

A molecular and cellular mapping of the fenestrated vasculture of the circumventricular organs: from physiology to pathology.

VesselCVO

In the brain, the blood vasculature harbours a unique specification: the Blood Brain Barrier (BBB), which restricts blood/brain exchanges to a select set of molecules. This particularity makes neurons blind to most peripheral signal. However, the peripheral organs and the brain have to communicate to maintain homeostasis and body functions such as...

Funding Programme
Start Date
End Date
Total Funding
€ 222 727
European Countries Involved

A non-inferiority randomized trial testing an advice of modeA non-inferiority randomized trial testing an advice of moderate drinking pattern versus advice on abstention on major disease and mortality

UNATI

Europeans are the largest alcohol consumers. Policymakers and clinicians are currently perplexed on how to reduce alcohol harms in drinkers, due to contradictory guidelines: abstention is proposed as the healthiest option by many health advocates, stating that there is no safe level of alcohol intake; but most nonrandomized studies found lower all...

Funding Programme
Start Date
End Date
Total Funding
€ 2 498 466
European Countries Involved

A novel approach for modelling the human nose-brain axis in vitro

Micro-SENSE

Olfactory neurons allow circumventing the blood-brain barrier making this route particularly interesting for the non-invasive intranasal treatment of brain diseases (Alzheimer’s Disease). Moreover, commensal nasal microbes present in the respiratory region, the major surface of the nasal cavity, are assumed to induce health-promoting effects via...

Funding Programme
Start Date
End Date
Total Funding
€ 172 750
European Countries Involved

A novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of Alzheimer's Disease

FluiDx-AD

FluiDx-AD aims to transform Alzheimer’s disease (AD) diagnosis and prepare the EU healthcare systems for the emergence of new AD therapies, with a 1st-in-class trio of In Vitro Diagnostics tests.FluiDx-AD tests detect a unique and proprietary suite of biomarkers in simple bodily fluids (saliva, plasma/blood), towards widespread, patient-empowering...

Funding Programme
Start Date
End Date
Total Funding
€ 7 699 219
European Countries Involved

A Novel Toolkit for the Early Diagnosis of Hearing Impairment (EDHI)

EDHI

Approximately 4060% of the European population is at risk of developing hearing loss due to exposure to unsafe noise levels. The EDHI fellowship will develop a novel toolkit sensitive to the first signs of hearing loss appropriate for use as an early diagnostic. This objective will be achieved by (1) ideating innovative behavioural and...

Funding Programme
Start Date
End Date
Total Funding
€ 181 152
European Countries Involved

A road to remember: Neural plasticity through the lens of gut-brain interactions

MemoryLane

The fact that the brain is influenced by the microorganisms that make up the gut microbiome substantially widens the scope of how we need to view human neurocognition and behaviour. However, a clear understanding of underlying mechanisms is scant and mainly grounded in animal work. This proposal aims at major contributions towards overcoming these...

Funding Programme
Start Date
End Date
Total Funding
€ 1 499 755
European Countries Involved

A therapeutic software that delivers remote speech therapy to individuals with Parkinson's disease

Teleatherapy

Parkinson’s disease (PD) is the second most common neurological disease worldwide after Alzheimer’s and is the fastest growing one. Over 10 million people in the world are living with this disease, of which about 90% will experience difficulties with their voice as the disease progresses.At Teleatherapy, our goal is to make speech and language...

Funding Programme
Start Date
End Date
Total Funding
€ 75 000
European Countries Involved

a toolkit for dynaMic health Impact analysiS to predicT disability-Related costs in the Aging population based on three case studies of steeL-industry exposed areas in europe

MISTRAL

The environment is one of the most crucial determinants of health. The Global Burden of Disease report estimates an emerging impact in terms of disability and reducing the quality of life worldwide, particularly for the aging populations. One of the root causes of this decline is likely to derive from the interaction of socio-environmental risk...

Funding Programme
Start Date
End Date
Total Funding
€ 3 619 635
European Countries Involved

Accelerating the Validation of Predictive Liquid Biomarkers for Frontotemporal Dementia Diagnosis and Subclassification

PREDICTFTD

Frontotemporal dementia (FTD) has a debilitating effect on patients and their caregivers and leads to substantial economic costs. 15-30% of patients have familial FTD caused by known pathogenetic mutations. For the other 70-85% of patients, termed sporadic FTD, diagnosis is slow (~3.6 years) with frequent misdiagnosis due to clinical, genetic and...

Funding Programme
Start Date
End Date
Total Funding
€ 7 994 911
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).